The purchase consideration is a payment of $70 million in cash. Centerview Partners LLC is acting as financial advisor and Goodwin Procter is serving as legal counsel to Repligen Corporation. Perella ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Repligen has acquired 908 Devices' desktop portfolio of four devices for bioprocessing process analytical technology applications for $70 million in cash.

Bio-Techne's Asuragen brand inks a partnership with Oxford Nanopore Technologies to launch research-use-only AmplideX Nanopore Carrier Plus Kit.

Executing initiatives to streamline priorities and drive approximately $30 million of annual cash operating expense reductionsReschedules fourth ...

The Global Antibody and Recombinant Protein Contract Development and Manufacturing Organization (CDMO) Market is witnessing remarkable growth, driven by the increasing demand for biologics and ...

Oxford Nanopore Technologies plc ( OTCPK:ONTTF) Q4 2024 Results Conference Call March 4, 2025 4:30 AM ET Gordon Sanghera - Chief Executive Officer Nick Keher - Chief Financial Officer ...

The aerospace composites market is driven by the rising demand for lightweight, fuel-efficient aircraft, advancements in composite material technologies, and the increasing adoption of carbon ...

Married at First Sight Australia 2025 is already shaping up to be a season full of jaw-dropping drama and spicy gossip. We've ...

Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify Hi, and welcome to The Long View. I’m Christine Benz, director of personal finance and retirement ...

We still didn't get a straight-up definition of exactly what an AI agent is during Bret Taylor's Mobile World Congress ...